Volume 5, Number 3, Supplement 2 (March 2008) |
| Emerging Therapies in Advanced Melanoma |
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of New York Medical College (NYMC) and the Continuing Education Alliance. To receive CME credit, print out, complete, and mail the evaluation form to New York Medical College, Office of Continuing Medical Education, Vosburgh Pavilion, Room 229, Valhalla, NY 10595, by March 15, 2009. |
|
Information About This CME Activity
Target audience • Faculty • Learning objectives • Faculty disclosures • How to receive credit • Disclaimer
| Release date: March 15, 2008 • Expiration date: March 15, 2009 |
|
Original Contributions |
4 |
|
Metastatic melanoma—challenges for the community oncologist Michael B. Atkins, MD Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
|
6 |
|
Melanoma biology: the foundation of therapy Michael K. K. Wong, MD, PhD, FRCPC Roswell Park Cancer Institute, Buffalo, NY
|
14 |
|
Promising immunotherapeutic approaches to the treatment of metastatic melanoma: modulation of the immune response Mario Sznol, MD Yale Cancer Center, New Haven, CT
|
23 |
|
Combination therapy: key data and ongoing studies combining targeted and cytotoxic agents Keith T. Flaherty, MD Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA
|
30 |
|
Self-assessment questions
|
33 |
|
Evaluation form and answer grid
|
This activity is supported by an unrestricted educational grant from Pfizer Inc. |
© 2008 by Elsevier Inc. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the publisher.
The opinions expressed herein are those of the authors or advertisers. The authors, editors, and publishers make every effort to ensure that no inaccurate or misleading data, opinion, or statement is published in this journal and that drug names, dosages, and recommendations are accurate. However, readers should confirm all dosage schedules against the manufacturer’s package information data. The Publisher, Editorial Board, and their employees accept no liability whatsoever for the consequences of any inaccurate or misleading data, opinion, or statement. |
87 kb